Castle Biosciences CSTL Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $116.73M-2.5% | $119.71M+21.1% | $98.84M-19.6% | $122.95M-62.7% | ||
| $5.59M— | $0-100% | $144.26M+6.3% | $135.68M— | ||
| $43.38M-15.3% | $51.22M+33.7% | $38.3M+63.2% | $23.48M+35.8% | ||
| $10.25M+26.0% | $8.14M+2.4% | $7.94M+99.5% | $3.98M+96.9% | ||
| $361.1M+0.3% | $360.15M+21.8% | $295.64M+1.1% | $292.29M-17.4% | ||
| $97.44M+90.6% | $51.12M+101% | $25.43M+77.7% | $14.32M+50.7% | ||
| $10.7M0.0% | $10.7M0.0% | $10.7M0.0% | $10.7M— | ||
| $88.88M-7.0% | $95.54M-10.4% | $106.64M-7.8% | $115.66M+30.1% | ||
| $578.56M+8.9% | $531.24M+17.2% | $453.34M+1.3% | $447.33M-3.3% | ||
| $18.71M+171% | $6.9M-32.8% | $10.27M+117% | $4.73M+85.8% | ||
| $417K+50.0% | $278K— | $0— | —— | ||
| $68.68M+39.0% | $49.39M+3.6% | $47.67M+31.9% | $36.13M+45.2% | ||
| $9.64M-1.1% | $9.75M— | $0— | —— | ||
| $107.68M+42.8% | $75.4M+21.5% | $62.07M+28.8% | $48.18M-5.2% | ||
| $30K+7.1% | $28K+3.7% | $27K0.0% | $27K+8.0% | ||
| -$224.28M-12.1% | -$200.13M+8.4% | -$218.37M-35.7% | -$160.91M-71.6% | ||
| $470.87M+3.3% | $455.84M+16.5% | $391.27M-2.0% | $399.15M-3.1% | ||
| $578.56M+8.9% | $531.24M+17.2% | $453.34M+1.3% | $447.33M-3.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Castle Biosciences's total assets?
- Castle Biosciences (CSTL) holds $547.8M in total assets, up 9.2% year over year.
- How much debt does Castle Biosciences have?
- Castle Biosciences carries $36.7M in total debt against $461.4M of shareholders' equity, a debt-to-equity ratio of 0.08.
- How much cash does Castle Biosciences have?
- Castle Biosciences holds $63.8M in cash and equivalents.
- Can Castle Biosciences cover its short-term obligations?
- Its current ratio is 6.75 — current assets exceed current liabilities.
- Where does Castle Biosciences's balance sheet data come from?
- Every line is extracted from Castle Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
